UK Markets open in 7 hrs

NuCana plc (NCNA)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
0.8897+0.0368 (+4.31%)
At close: 04:00PM EDT
0.9100 +0.02 (+2.28%)
After hours: 07:51PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close0.8529
Open0.8600
Bid0.8610 x 900
Ask0.9000 x 1100
Day's range0.8201 - 0.8999
52-week range0.5170 - 2.2400
Volume152,622
Avg. volume158,133
Market cap46.439M
Beta (5Y monthly)1.34
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
All
News
  • Globe Newswire

    Technical Board of Appeal of the European Patent Office Issues Oral Ruling that NuCana’s ‘190 Patent is Not Valid

    Ruling Has No Impact on NuCana’s Anti-Cancer ProTide PatentsMUNICH, Germany, March 24, 2023 (GLOBE NEWSWIRE) -- NuCana plc (NASDAQ: NCNA) announced that, following a hearing on March 24, 2023, the Technical Board of Appeal (the “TBA”) of the European Patent Office (the “EPO”) issued an oral judgement that NuCana’s European Patent 2955190 (the “’190 patent”) is not valid. The TBA reversed the previous decisions of the EPO’s Examination Division which issued NuCana’s ‘190 patent and of the EPO’s O

  • Globe Newswire

    NuCana to Participate in Two Upcoming Investor Conferences

    EDINBURGH, United Kingdom, Feb. 28, 2023 (GLOBE NEWSWIRE) -- NuCana plc (Nasdaq: NCNA) announced today that Hugh Griffith, Chief Executive Officer, and Don Munoz, Chief Financial Officer, will participate in two upcoming investor conferences. Event: Cowen’s 43rd Annual Healthcare Conference Presentation Date: Tuesday, March 7, 2023Presentation Time: 10:30 AM ET Event: Oppenheimer's 33rd Annual Healthcare Conference Presentation Date: Tuesday, March 14, 2023Presentation Time: 12:40 PM ET The pres

  • Globe Newswire

    NuCana Regains Compliance with Nasdaq Minimum Bid Price Requirement

    EDINBURGH, United Kingdom, Jan. 23, 2023 (GLOBE NEWSWIRE) -- NuCana plc (NASDAQ: NCNA), (“NuCana” or the “Company”), announced that it has received a written notification (the “Notification Letter”) from the Listing Qualifications Department of the Nasdaq Stock Market, LLC (“Nasdaq”) informing the Company that it has regained compliance with the minimum bid price requirement for continued listing set forth in Nasdaq Listing Rule 5450(a)(1) (the “Minimum Bid Price Requirement”) and the matter is